EG17702A - Improvements in or relating to the synthesis of nizatidine - Google Patents

Improvements in or relating to the synthesis of nizatidine

Info

Publication number
EG17702A
EG17702A EG92/84A EG9284A EG17702A EG 17702 A EG17702 A EG 17702A EG 92/84 A EG92/84 A EG 92/84A EG 9284 A EG9284 A EG 9284A EG 17702 A EG17702 A EG 17702A
Authority
EG
Egypt
Prior art keywords
nizatidine
relating
synthesis
methyl
ylmethylthio
Prior art date
Application number
EG92/84A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23843341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG17702(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG17702A publication Critical patent/EG17702A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Credit Cards Or The Like (AREA)
EG92/84A 1983-02-07 1984-02-07 Improvements in or relating to the synthesis of nizatidine EG17702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46429683A 1983-02-07 1983-02-07

Publications (1)

Publication Number Publication Date
EG17702A true EG17702A (en) 1991-03-30

Family

ID=23843341

Family Applications (1)

Application Number Title Priority Date Filing Date
EG92/84A EG17702A (en) 1983-02-07 1984-02-07 Improvements in or relating to the synthesis of nizatidine

Country Status (27)

Country Link
EP (1) EP0116452B1 (xx)
JP (1) JPS59152378A (xx)
KR (1) KR860000767B1 (xx)
AT (1) ATE84530T1 (xx)
AU (1) AU559639B2 (xx)
BG (1) BG45216A3 (xx)
CA (1) CA1221369A (xx)
CS (1) CS240994B2 (xx)
DD (1) DD216459A5 (xx)
DE (1) DE3486032T2 (xx)
DK (2) DK164501C (xx)
EG (1) EG17702A (xx)
ES (1) ES8601941A1 (xx)
FI (1) FI840474A (xx)
GB (1) GB2134521B (xx)
GR (1) GR81755B (xx)
HU (2) HU190527B (xx)
IE (1) IE56763B1 (xx)
IL (1) IL70880A (xx)
NZ (1) NZ207046A (xx)
PH (1) PH19941A (xx)
PL (1) PL138793B1 (xx)
PT (1) PT78063A (xx)
RO (1) RO87706A (xx)
SU (1) SU1303028A3 (xx)
UA (1) UA6020A1 (xx)
ZA (1) ZA84869B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
DE3486032T2 (de) 1993-05-19
DK164501C (da) 1992-11-23
JPH0576473B2 (xx) 1993-10-22
DK164906B (da) 1992-09-07
EP0116452A2 (en) 1984-08-22
ATE84530T1 (de) 1993-01-15
FI840474A0 (fi) 1984-02-06
ES529492A0 (es) 1985-11-01
DK164501B (da) 1992-07-06
GB2134521B (en) 1986-10-01
KR840007591A (ko) 1984-12-08
CS240994B2 (en) 1986-03-13
GB2134521A (en) 1984-08-15
HU194198B (en) 1988-01-28
HU190527B (en) 1986-09-29
NZ207046A (en) 1986-06-11
GB8403109D0 (en) 1984-03-07
PL138793B1 (en) 1986-11-29
DK51984D0 (da) 1984-02-06
FI840474A (fi) 1984-08-08
AU2421584A (en) 1984-08-16
RO87706B (ro) 1985-10-01
GR81755B (xx) 1984-12-12
ZA84869B (en) 1985-09-25
EP0116452B1 (en) 1993-01-13
IE840274L (en) 1984-08-07
DK164906C (da) 1993-01-25
IE56763B1 (en) 1991-12-04
DK51984A (da) 1984-08-08
JPS59152378A (ja) 1984-08-31
DK21292A (da) 1992-02-19
CA1221369A (en) 1987-05-05
RO87706A (ro) 1985-10-31
UA6020A1 (uk) 1994-12-29
BG45216A3 (bg) 1989-04-14
PT78063A (en) 1984-03-01
PH19941A (en) 1986-08-14
KR860000767B1 (ko) 1986-06-23
IL70880A (en) 1987-01-30
EP0116452A3 (en) 1987-04-29
DD216459A5 (de) 1984-12-12
ES8601941A1 (es) 1985-11-01
DE3486032D1 (de) 1993-02-25
IL70880A0 (en) 1984-05-31
SU1303028A3 (ru) 1987-04-07
AU559639B2 (en) 1987-03-19
CS81284A2 (en) 1985-06-13
PL246097A1 (en) 1985-06-04
DK21292D0 (da) 1992-02-19

Similar Documents

Publication Publication Date Title
DE3175042D1 (en) 7-oxo-4-thia-1-aza(3,2,0)heptane and 7-oxo-4-thia-1-aza(3,2,0)hept-2-ene derivatives
EP0181001A3 (en) Polypeptide, a process for preparing the same, a pharmaceutical composition containing said polypeptide as well as the use thereof
DE3374865D1 (en) Process for preparing 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide
GB2134521B (en) Improvements in or relating to the synthesis of nizatidine
FR2370074A1 (fr) Sulfonyltetrazoles utilisables comme porogenes
RO83439B (ro) Procedeu pentru repararea n-cian-n'-metil-n"-(2-((5metil-1h-imidazol-4-il)-metil)-tio)-etil-guanidinei
ES8301942A1 (es) Un procedimiento para la preparacion de acidos dialupilos s-sustituidos.
DE3760618D1 (en) Synthesis of bicyclic aromatic sulfonyl chlorides
CA1273347C (xx)
IL101915A0 (en) Process for preparing intermediates to nizatidine and related compounds